drugset / Trial / NCT03623984
Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if the use of 68Gallium- positron emission tomography and computer tomography (PET/CT) scans along with NETSPOT® (Advanced Accelerator Applications USA, Inc.) can better define the localization of Neuroendocrine tumors enhancing the surgical removal of Neuroendocrine tumors (NETs).
Timeline
- Start
- 2019-06-07
- Primary completion
- 2022-06-07
- Completion
- 2023-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-DOTATATE | Diagnostic / imaging agent | — | Other |